June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Development of a simple driving simulator (DS) with gaze-tracking system and factors and visual subfield relating to the DS-collision in glaucoma patients
Author Affiliations & Notes
  • Aiko Iwase
    Ophthalmology, Tajimi Iwase Eye Clinic, Tajimi, Japan
  • Makoto Araie
    Kanto Central Hospital of the Mutual Aid Association of Public School Teachers, Tokyo, Japan
  • Shiho Kunimatsu-Sanuki
    Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Japan
  • Hiroshi Ono
    Honda Motor Co, Tokyo, Japan
  • Yuto Susuki
    Division of Health Sciences, Osaka University Graduate School of Medicine, Osaka, Japan
  • Yuko Ohno
    Division of Health Sciences, Osaka University Graduate School of Medicine, Osaka, Japan
  • Footnotes
    Commercial Relationships Aiko Iwase, None; Makoto Araie, None; Shiho Kunimatsu-Sanuki, None; Hiroshi Ono, Honda Motor Co (E); Yuto Susuki, None; Yuko Ohno, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 1040. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Aiko Iwase, Makoto Araie, Shiho Kunimatsu-Sanuki, Hiroshi Ono, Yuto Susuki, Yuko Ohno; Development of a simple driving simulator (DS) with gaze-tracking system and factors and visual subfield relating to the DS-collision in glaucoma patients. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):1040.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: An adequate visual field (VF) is a requisite for safe driving and effects of glaucoma on motor vehicle accident (MVA) involvement have been vigorously studied. A driving simulator (DS) is often used to create controlled conditions for evaluation of driving performance, but most DSs are not equipped with gaze monitoring system which is indispensable for correlating VF abnormalities to MVA involvement. We studied effects of glaucomatous VF on collision using a DS systen equipped with a gaze-tracking system.

Methods: A modified version of Honda safety Navi DS System (Honda Motor Co., Tokyo) which reproduces the driver's view from a right-hand-drive car on the screen 114 cm apart was equipped with a gaze-tracking system (NAC EMR-9, nac Image Technology, Tokyo), and the driver's gaze point (DGP) was monitored in real-time on a personal computer display which also reproduced the driver's view. The instant when the driver first detected the hazard was determined by a saccadic movement of the DGP toward the hazard. The driver's binocular integrated VF (IVF) calculated by merging the 2 monocular Humphrey Field Analyzer 24-2 Swedish Interactive threshold Algorithm (Carl Zeiss Meditec., CA) test results and centered on the DGP just before detecting the hazard was projected onto the driver's view. 52 glaucoma patients (66.2+/-9.2 yrs.; mean deviation (MD) of the better eye=-8.1+/-6.3 dB; mean IVF sensitivity=22.0+/-6.0 dB) participated in the DS experiment and were required to avoid an oncoming right-turning car, the hazard, at an intersection. The Ethic Committee of Gifu Prefecture Medical Association approved the study.

Results: 15 of the 52 collided with the hazard. It took longer time for the collision-involved examinees to detect the hazard than those not (0.65+/-0.66 vs. 0.25+/-0.30 sec, P=0.012). The decision tree method correlated 3 IVF test points to the collision and sensitivity was lower in the former than the latter at a point just inferior and right to the fixation (22.0+/-3.8 vs. 29.8+/-5.8 dB, P=0.016). Visual acuity and MD of the dominant eye were also correlated with the collision (k=0.59, Partition, JMP Pro11.0,SAS)

Conclusions: A DS with a gaze-tracking system was developed, which enabled us to study the location and sensitivity of the patient's IVF subfield related to MVA involvement in a given scenario of DS.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×